Study for mechanism and efficacy of acupuncture in the treatment of severe premenstrual syndrome

Phase 1

Recruiting

• Conditions: Women and children's disease; 2015M01

• Registration Number: ITMCTR1900002425
• Lead Sponsor: First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Women aged between 18 and 35, who met the diagnostic criteria of moderate and severe premenstrual tension syndrome;
2. The regularity of menstrual cycle is 28-35 days;
3. Ability to read and write;
4. Voluntarily to be involved in the study and sign the informed consent;
5. The total score of DRSP in the first five days of two consecutive menstrual cycles is greater than or equal to 130 points.

Exclusion Criteria

1. With serious heart, brain and kidney diseases, hypertension, diabetes and so on;
2. Recent six months of treatment for premenstrual tension syndrome;
3. Recent month received other medication;
4. It is anticipated that during the study period, the treatment of subjects with more than one menstrual cycle will be discontinued. Can not attend follow-up as required (telephone or e-mail follow-up);
5. Participate in other clinical researchers in the past month;
6. Recent six months received psychiatric drugs or other medications that affected the study;
7. Pregnant subjects or planned pregnant subjects;
8. Pelvic ultrasound has any organic lesions;
9. Have a history of mental illness;
10. Take analgesics in the past month;
11. Acupuncture treatment has been given in the past six months;
12. There are subjects with alcohol abuse, drug abuse history, attempted suicide and severe personality disorders. Alcohol abuse is defined as > 14 cups per week or binge drinking.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurotransmitter indices;DRSP Rating;Serum hormone index;